Using nonpathogenic Newcastle disease virus (NDV) as an oncolytic virus resulted in increased infiltration of effecter T cells, but that was eventually inhibited through upregulation of PD-L1 in tumour cells and immune cells in the TME [101]. This evidence concerns the gene CD274 and neoplasm.